Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Biological functions made printable: smart bioprinting with agency and control over cell fate and human tissue development

Project description

Adaptive 3D bioprinting

3D bioprinting shapes living tissue with precision. However, structural form alone does not create function. Cells in the body naturally mature and adapt to their environment over time. Standard printers cannot monitor this growth. This limitation slows the development of functional human organs. The ERC-funded SMART-AGENT project aims to develop adaptive, light-based bioprinters that can ‘see’ the tissue they build, using advanced imaging, computer vision and AI. By combining biofabrication with optogenetics, the system will steer cell behaviour in real time through targeted light signals. The project will test the technology by creating vascularised models of the human endocrine pancreas, opening new paths to study diabetes and engineer functional tissue.

Objective

Three-dimensional bioprinting holds the promise to transform medicine and biology by assembling living matter into lab-made human tissues. Today’s bioprinting excels at producing anatomical shapes, to an extent unmatched by other technologies. However, in native tissues, biological function is intimately linked to architecture, but also tissue maturation and morphogenesis, processes that dynamically evolve as cells respond to environmental stimuli. Bioprinting has no way to follow maturation over time and intervene to guide cells, severely limiting the ability to fully mimic organ functions. Capturing and controlling tissue’s adaptive behaviour in bioprinted tissues can bring the long sought goal of engineering organ parts and its revolutionary potential within reach.

To achieve this goal, SMART-AGENT introduces a groundbreaking adaptive bioprinting technology able to directly instruct cells and guide tissue maturation with exquisite spatial and temporal precision. To make this possible, I will develop light-based printers that, leveraging advanced imaging, computer vision, and artificial intelligence, are able to “see” and “understand” the content and composition (cellular, chemical, architectural) of the printing environment. Elaborating this information, printers will automatically make decisions on how to generate printed parts and how to intervene directly on cell behaviour at any desired moment. Converging biofabrication and optogenetics, our adaptive bioprinting suite will trigger programmable cell response via light stimuli provided by the printer itself, effectively making cell functions 3D printable. Bringing together my unique expertise in photonics, bioprinting, cell engineering and synthetic biology, I will first assess the potential of this technology by developing vascularized human endocrine pancreas models with physiological-like function. This will open new avenues to study diabetes and to investigate human biology with unprecedented precision.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

UNIVERSITEIT UTRECHT
Net EU contribution
€ 2 312 492,00
Address
HEIDELBERGLAAN 8
3584 CS Utrecht
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 312 492,00

Beneficiaries (1)